advertisement
Vertex Pharm downgraded to "market perform"
09/08/10 - JMP Securities
NEW YORK, September 8 (newratings.com) - Analysts at JMP Securities downgrade Vertex Pharm (VRTX) from "market outperform" to "market perform."
Share Recommend this article to a friend
add VRTX to my stocks and get e-mail alerts on Vertex Pharmaceuticals
News